Cargando…
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation
It is an effective strategy to treat tuberculosis by enhancing reactive oxygen species- (ROS-) mediated killing of Mycobacterium tuberculosis in macrophages, but there are no current therapeutic agents targeting this pathway. Honeysuckle has been used as the traditional medicine for tuberculosis tre...
Autores principales: | Wan, Haoqiang, Cai, Yi, Xiao, Lingyun, Ling, Yunzhi, Ge, Lanlan, Mo, Siwei, Xie, Qiujie, Peng, Shusong, Zhou, Boping, Zeng, Xiaobin, Chen, Xinchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937762/ https://www.ncbi.nlm.nih.gov/pubmed/36819778 http://dx.doi.org/10.1155/2023/6726654 |
Ejemplares similares
-
The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017) -
Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021) -
Structural basis of Keap1 interactions with Nrf2
por: Canning, Peter, et al.
Publicado: (2015) -
Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
por: Bhattacharjee, Shamee, et al.
Publicado: (2020) -
The KEAP1/NRF2 Signaling Pathway in Keratinization
por: Ishitsuka, Yosuke, et al.
Publicado: (2020)